CSPC Pharmaceutical Dividend yield

CSPC Pharmaceutical is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. CSPC Pharmaceutical is a company from China, and his stocks are publicly traded.

CSPC Pharmaceutical stock dividend

CSPC Pharmaceutical paid a total dividend of 2,506 million HKD last year, for a market value of 70,405 millions (Market Cap 49,285 millions). CSPC Pharmaceutical dividend per share is 0.21 HKD, and his stock market price 5.90 HKD.

According to the chart below, where dividend yield is displayed, CSPC Pharmaceutical has a dividend yield of 3.56%, which is higher than the amount offered by both the market average and companies from China. It is also bigger than average of Health Care industry. This high dividend yield might be a sign to worry about the future of the company so deeper analysis is needed.

In addition, you should compare CSPC Pharmaceutical stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the best China dividend stocks list.

CSPC Pharmaceutical Dividend Payout

About the ability of CSPC Pharmaceutical to maintain his current dividend of HKD 0.21 per share, an amount that accounts for 3.56%, we should study its payout ratio both on earnings and on cash-flows (see chart below). CSPC Pharmaceutical payout on ernings is currently 35.00%, which is lower than the market average, but higher than companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that CSPC Pharmaceutical is in a good position to keep maintaining his dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of CSPC Pharmaceutical is HKD 0.78 per share, which is higher than the dividend per share paid by the company of HKD 0.21, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of CSPC Pharmaceutical, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

CSPC Pharmaceutical Dividend History

Below you will find a table with the historical evolution of CSPC Pharmaceutical's dividend stock, both in percentage and in HKD, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).

Year	Yield	HKD	Paypout	Shares*
Present	3.56%	0.21	35.00%	11,933
2022	2.44%	0.20	35.09%	11,933
2021	2.01%	0.17	34.69%	11,974
2020	1.79%	0.14	40.00%	11,974
2019	0.97%	0.18	30.51%	6,236
2018	1.33%	0.15	32.61%	6,243
2017	0.76%	0.12	35.29%	6,243
2016	1.32%	0.11	37.93%	5,908
2015	1.37%	0.10	45.45%	5,908

*In millions

Then you can see the evolution of CSPC Pharmaceutical dividend stock, and compare it with the average of China stocks and that of the Pharmaceuticals and Biotechnology stocks.

CSPC Pharmaceutical Stock performance

Finally, last moth CSPC Pharmaceutical showed a return of -9.10% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a -26.20% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.